addiction
TGA seeks submissions on codeine options
The TGA is seeking further advice and submissions from stakeholders in regard to newly proposed options for the future scheduling of OTC codeine-containing preparations. Last month it deferred its final …
Codeine rescheduling delay causing harm: ScriptWise
The TGA decision to defer the rescheduling of codeine-containing OTC medications conflicts with rising codeine analgesics misuse, its devastating consequences and the recognition that opioid misuse is a public health …
Drug and alcohol roundup: health issues
Recently the fifth IGCD Stakeholder Forum was held in Melbourne. Delegates from around Australia participated in discussions that would shape the policy on how we would manage drug use for …
Guild moving on harm minimisation: Tambassis
The deferral of a decision on codeine scheduling will give the Guild time to address the problem of codeine dependence, national president George Tambassis said in his address to the …
Time allows Regulation Impact Statement on codeine: PSA
The Pharmaceutical Society of Australia has welcomed the deferral of a final decision on the possible rescheduling of codeine. PSA National President, Joe Demarte says that the extra time allowed …
Stakeholders gear up on real-time codeine monitoring
The deferment of a final decision on the upscheduling of codeine-containing OTCs is very good news, but stakeholders now need to get moving quickly on the proposed real-time monitoring system …
Codeine stays OTC… for now
Over-the-counter medicines containing codeine will remain OTC until at least 2017, the TGA has announced. A delegate of the Secretary to the Department of Health gave notice of the deferment …
Codeine crackdown could cost $1.27 billion over four years… and more
Upscheduling codeine-containing OTCs could cost upwards of $1.27 billion in MBS outlay alone over the next four years, a new report has found. The Pharmacy Guild engaged Cadence Economics to …
Why upscheduling codeine combination products is a really bad idea
Professor Peter Carroll, Dr Rebekah Moles, Dr Slade Matthews, Stuart Nankivell and Nick Logan (Members of the NSW Poisons Advisory Committee) on why they think upscheduling combination codeine products is …
Why it’s hard to justify upscheduling codeine OTCs: Schoombie
As the final decision on OTC codeine scheduling draws near, ASMI’s Deon Schoombie ponders some of the drawbacks of upscheduling In the lead up to the announcement of the final …
Guild slams codeine deaths claims
The Guild has hit back at claims that pushback against the interim decision to reschedule codeine-containing OTCs to prescription only do not adequately take into account safety issues. Pain specialist …
Codeine ‘scare campaign’ ignores harms: pain specialist
Efforts to retain pain and cold/flu medications which contain codeine on the Pharmacist Only schedule are misguided, says a pain expert. “There’s a scare campaign going on, which really doesn’t …